ReviewFrontiers in oncology2026

Evolving treatment strategies for HER2-altered non-small-cell lung cancer: the rise of TKIs and ADCs.

Sevinc Balli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.